Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer

INTRODUCTION: Approximately 30% of patients diagnosed with stage Ia-b NSCLC die of recurrent disease after surgery. This study aimed to identify immune-related biomarkers that might predict tumor recurrence in stage Ia-b NSCLC within 40 months after curative resection. METHODS: Gene expression data...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiang, Zhou, Danting, Wu, Fang, Liang, Qingchun, He, Qiongzhi, Peng, Muyun, Yao, Tianyu, Hu, Yan, Qian, Banglun, Tang, Jingqun, Wang, Xiang, Liu, Wenliang, Yu, Fenglei, Chen, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356052/
https://www.ncbi.nlm.nih.gov/pubmed/34395248
http://dx.doi.org/10.3389/fonc.2021.680287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356052/
https://www.ncbi.nlm.nih.gov/pubmed/34395248
http://dx.doi.org/10.3389/fonc.2021.680287

Ejemplares similares